Drugs in R and D
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.5 | Q3 | 42.7% | 0.918 | Q2 | 81.6% |
| 2024 | 2.1 | Q3 | 37.4% | 0.691 | Q2 | 73.1% |
| 2023 | 2.2 | Q3 | 44.3% | 0.708 | Q2 | 76.1% |
| 2022 | 3.0 | Q3 | 53.3% | 0.666 | Q2 | 75.3% |
| 2021 | 3.2 | Q3 | 53.0% | 0.665 | Q2 | 76.0% |
| 2020 | — | — | 0.873 | Q2 | 82.1% | |
| 2019 | — | — | 0.585 | Q2 | 71.9% | |
| 2018 | — | — | 0.833 | Q2 | 79.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1174-5886
ISSN
1179-6901
country
CHcoverage
1999, 2002-2008, 2010-2025